SCHEMBL30300

SCHEMBL30300

C=CCOC(=O)C(CCCCN=C=O)N=C=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626963 1.00 TDP1 (0.31) TDP1
SCHEMBL725896 0.90 TDP1 (0.33) TDP1
SCHEMBL21891819 0.83
SCHEMBL11586545 0.83 TSHR (0.49) TDP1
SCHEMBL11586707 0.83 TSHR (0.49) TDP1
SCHEMBL10451042 0.82 TSHR (0.44) TDP1
SCHEMBL23721647 0.82
SCHEMBL10861388 0.82
SCHEMBL1271466 0.82
SCHEMBL133255 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 806 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3679013-B1 METHOD FOR MAKING ISOCYANATES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-11-29 EP claimed
US-20230149289-A1 COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED ELASTICITY AND EXTENSIBILITY COVESTRO DEUTSCHLAND AG (DE) 2023-05-18 US claimed
EP-4114347-A1 COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED ELASTICITY AND EXTENSIBILITY Covestro Deutschland AG (DE) 2023-01-11 EP claimed
CN-115209863-A Cosmetic composition for forming film with improved elasticity and extensibility 科思创德国股份有限公司 2022-10-18 CN claimed
CN-111051276-B Method for producing isocyanates 科思创德国股份有限公司 2022-09-09 CN claimed
US-20220049051-A1 PROCESS FOR PREPARING A POLYESTER USING A 4-MEMBERED RING LACTONE COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-02-17 US claimed
EP-3898759-A1 PROCESS FOR PREPARING A POLYESTER USING A 4-MEMBERED RING LACTONE Covestro Intellectual Property GmbH & Co. KG (DE) 2021-10-27 EP claimed
EP-3758802-A1 COSMETIC COMPOSITION TO IMPROVE THE RESISTANCE OF A HAIRSTYLE Covestro Intellectual Property GmbH & Co. KG (DE) 2021-01-06 EP claimed
US-20200390681-A1 COSMETIC COMPOSITION TO IMPROVE THE RESISTANCE OF A HAIRSTYLE COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2020-12-17 US claimed
US-10858310-B1 Method for producing isocyanates COVERSTRO DEUTSCHLAND AG (DE) 2020-12-08 US claimed
CN-103492443-A Reinforced pultruded polyurethane and production thereof BAYER IP GMBH 2014-01-01 CN claimed
EP-2668221-A1 REINFORCED PULTRUDED POLYURETHANE AND PRODUCTION THEREOF Bayer Intellectual Property GmbH (DE) 2013-12-04 EP claimed
US-20130309924-A1 REINFORCED PULTRUDED POLYURETHANE AND PRODUCTION THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-11-21 US claimed
US-20130209729-A1 GENERATION OF MIXED DIISOCYANATES BY PHOSGENATION OF SOY BASED METHYL AMINO ESTERS INVENTURE RENEWABLES, INC. (US) 2013-08-15 US claimed
WO-2013004653-A1 LAYER STRUCTURE FOR CLOSING TISSUE LEAKAGES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-01-10 WO claimed
EP-2543395-A1 Layer construction for closing tissue leaks Bayer MaterialScience AG (DE) 2013-01-09 EP claimed
US-20120244107-A1 BIODEGRADABLE HYDROGEL BAYER MATERIALSCIENCE AG (DE) 2012-09-27 US claimed
EP-2490728-A1 BIODEGRADABLE HYDROGEL Bayer Materialscience AG (DE) 2012-08-29 EP claimed
WO-2012101085-A1 REINFORCED PULTRUDED POLYURETHANE AND PRODUCTION THEREOF BAYER MATERIALSCIENCE AG (DE) 2012-08-02 WO claimed
WO-2011047789-A1 BIODEGRADABLE HYDROGEL BAYER MATERIALSCIENCE AG (DE) 2011-04-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149289-A1 COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED ELASTICITY AND EXTENSIBILITY POLR1C, CUTA, SUCLG1 TDP1 568/4885
US-20200390681-A1 COSMETIC COMPOSITION TO IMPROVE THE RESISTANCE OF A HAIRSTYLE CUTA, UROD, USP7 TDP1 2334/4885
US-10858310-B1 Method for producing isocyanates IDH2, ADH5, ADH1C TDP1 1808/4885
US-20130209729-A1 GENERATION OF MIXED DIISOCYANATES BY PHOSGENATION OF SOY BASED METHYL AMINO ESTERS PFAS, PRMT9, DDAH1 TDP1 3074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.